Skip Nav Destination
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up
Rituximab in the treatment of acquired factor VIII inhibitors
Issue Archive
November 1 2002
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
Clinical Trials & Observations
Paul G. Richardson,Robert L. Schlossman,Edie Weller,Teru Hideshima,Constantine Mitsiades,Faith Davies,Richard LeBlanc,Laurence P. Catley,Deborah Doss,Kathleen Kelly,Mary McKenney,Julie Mechlowicz,Andrea Freeman,Reggie Deocampo,Rebecca Rich,Joan J. Ryoo,Dharminder Chauhan,Kathe Balinski,Jerome Zeldis,Kenneth C. Anderson
REVIEW ARTICLES
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation
Clinical Trials & Observations
Andy C. Rawstron,Faith E. Davies,Ranjit DasGupta,A. John Ashcroft,Russell Patmore,Mark T. Drayson,Roger G. Owen,Andrew S. Jack,J. Anthony Child,Gareth J. Morgan
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation
Clinical Trials & Observations
David I. Marks,Richard Lush,Jamie Cavenagh,Donald W. Milligan,Steven Schey,Anne Parker,Fiona J. Clark,Linda Hunt,John Yin,Steven Fuller,Elisabeth Vandenberghe,Judith Marsh,Timothy Littlewood,Graeme M. Smith,Dominic Culligan,Ann Hunter,Rajesh Chopra,Andrew Davies,Keiren Towlson,Catherine D. Williams
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia
Clinical Trials & Observations
Holger Schulz,Saskia Karina Klein,Ute Rehwald,Marcel Reiser,Axel Hinke,Wolfgang-Ulrich Knauf,Walter-Erich Aulitzky,Manfred Hensel,Michael Herold,Dieter Huhn,Michael Hallek,Volker Diehl,Andreas Engert,on behalf of the German CLL Study Group (GCLLSG)
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders
Clinical Trials & Observations
José A. Pérez-Simón,Panagiotis D. Kottaridis,Rodrigo Martino,Charles Craddock,Dolores Caballero,Raj Chopra,Javier Garcı́a-Conde,Don W. Milligan,Stephen Schey,Alvaro Urbano-Ispizua,Anne Parker,Angel Leon,Kwee Yong,Ana Sureda,Ann Hunter,Jordi Sierra,Anthony H. Goldstone,David C. Linch,Jesus F. San Miguel,Stephen Mackinnon,for the Spanish and United Kingdom Collaborative Groups for Nonmyeloablative Transplantation
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study
Clinical Trials & Observations
Mohamad Mohty,Mathieu Kuentz,Mauricette Michallet,Jean-Henri Bourhis,Noël Milpied,Laurent Sutton,Jean-Pierre Jouet,Michel Attal,Pierre Bordigoni,Jean-Yves Cahn,Jean-Michel Boiron,Didier Blaise,for the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)
Clinical Trials & Observations
Loı̈c Fouillard,Myriam Labopin,Norbert-Claude Gorin,Emmanuelle Polge,Hugh Grant Prentice,Giovanna Meloni,Josy Reiffers,Arnaud Pigneux,Roel Willemze,Anton Schattenberg,Simona Sica,Monique Lagrange,Odile Fenneteau,Christine Perot,Francesco Frassoni,for the Acute Leukemia Working Party of the EBMT
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up
Clinical Trials & Observations
Giuseppe Avvisati,Maria Concetta Petti,Francesco Lo-Coco,Maria Luce Vegna,Sergio Amadori,Michele Baccarani,Nicola Cantore,Eros Di Bona,Felicetto Ferrara,Giuseppe Fioritoni,Eugenio Gallo,Rosangela Invernizzi,Mario Lazzarino,Vincenzo Liso,Guglielmo Mariani,Francesco Ricciuti,Carmine Selleri,Simona Sica,Dino Veneri,Franco Mandelli,for the Italian Cooperative Group GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto)
GENE THERAPY
Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation
Katharine A. Whartenby,Erin E. Straley,Heeje Kim,Frederick Racke,Vivek Tanavde,Kevin S. Gorski,Linzhao Cheng,Drew M. Pardoll,Curt I. Civin
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines
Maria Wysocka,Mohamed H. Zaki,Lars E. French,Jihed Chehimi,Michael Shapiro,Suzanne E. Everetts,Karen S. McGinnis,Luis Montaner,Alain H. Rook
Subtractive hybridization reveals the expression of immunoglobulinlike transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells
Marie-Clotilde Rissoan,Thomas Duhen,Jean-Michel Bridon,Nathalie Bendriss-Vermare,Catherine Péronne,Blandine de Saint Vis,Francine Brière,Elizabeth E. M. Bates
NEOPLASIA
PHAGOCYTES
RED CELLS
TRANSPLANTATION
BRIEF REPORTS
Rituximab in the treatment of acquired factor VIII inhibitors
Clinical Trials & Observations
Brief Report
Adrian Wiestner,Hearn J. Cho,Adam S. Asch,Mary Ann Michelis,Jack A. Zeller,Ellinor I. B. Peerschke,Babette B. Weksler,Geraldine P. Schechter
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals